

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 9.50298694 |
| 2 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 9.46464279 |
| 3 | leukotriene biosynthetic process (GO:0019370) | 9.06904912 |
| 4 | * angiotensin maturation (GO:0002003) | 9.03574391 |
| 5 | regulation of mast cell degranulation (GO:0043304) | 8.93395649 |
| 6 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 8.89890013 |
| 7 | regulation of mast cell activation involved in immune response (GO:0033006) | 8.42737023 |
| 8 | positive regulation of regulated secretory pathway (GO:1903307) | 8.37359374 |
| 9 | tyrosine phosphorylation of STAT protein (GO:0007260) | 8.09255476 |
| 10 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 7.80986882 |
| 11 | thrombin receptor signaling pathway (GO:0070493) | 7.63801018 |
| 12 | imidazole-containing compound metabolic process (GO:0052803) | 7.63398028 |
| 13 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 7.10460662 |
| 14 | regulation of leukocyte degranulation (GO:0043300) | 6.81172498 |
| 15 | regulation of mast cell activation (GO:0033003) | 6.71959242 |
| 16 | leukotriene metabolic process (GO:0006691) | 5.72662070 |
| 17 | regulation of regulated secretory pathway (GO:1903305) | 5.69505949 |
| 18 | regulation of tolerance induction (GO:0002643) | 5.69299248 |
| 19 | regulation of T cell tolerance induction (GO:0002664) | 5.65637673 |
| 20 | regulation of megakaryocyte differentiation (GO:0045652) | 5.52844872 |
| 21 | positive regulation of chemokine secretion (GO:0090197) | 5.46515446 |
| 22 | mast cell activation involved in immune response (GO:0002279) | 5.30221427 |
| 23 | mast cell degranulation (GO:0043303) | 5.30221427 |
| 24 | actin nucleation (GO:0045010) | 5.23374745 |
| 25 | mast cell activation (GO:0045576) | 4.79524842 |
| 26 | serotonin metabolic process (GO:0042428) | 4.75912237 |
| 27 | definitive hemopoiesis (GO:0060216) | 4.72487154 |
| 28 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 4.69585283 |
| 29 | positive regulation of acute inflammatory response (GO:0002675) | 4.60292673 |
| 30 | monoamine transport (GO:0015844) | 4.58215431 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.56609511 |
| 32 | lipoxygenase pathway (GO:0019372) | 4.55351847 |
| 33 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 4.44919402 |
| 34 | megakaryocyte development (GO:0035855) | 4.43273944 |
| 35 | cytokine biosynthetic process (GO:0042089) | 4.41977644 |
| 36 | regulation of chemokine biosynthetic process (GO:0045073) | 4.31245865 |
| 37 | regulation of T cell cytokine production (GO:0002724) | 4.30577048 |
| 38 | cytokine metabolic process (GO:0042107) | 4.29033864 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.26010361 |
| 40 | T cell apoptotic process (GO:0070231) | 4.20446955 |
| 41 | regulation of chemokine secretion (GO:0090196) | 4.00460687 |
| 42 | platelet dense granule organization (GO:0060155) | 3.99242963 |
| 43 | germ cell migration (GO:0008354) | 3.98604857 |
| 44 | positive regulation of B cell mediated immunity (GO:0002714) | 3.91146726 |
| 45 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.91146726 |
| 46 | primary amino compound metabolic process (GO:1901160) | 3.90395160 |
| 47 | cytokine production involved in immune response (GO:0002367) | 3.87223640 |
| 48 | neutrophil mediated immunity (GO:0002446) | 3.85833146 |
| 49 | icosanoid biosynthetic process (GO:0046456) | 3.85555416 |
| 50 | fatty acid derivative biosynthetic process (GO:1901570) | 3.85555416 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.74342739 |
| 52 | cellular response to exogenous dsRNA (GO:0071360) | 3.69866689 |
| 53 | positive regulation of granulocyte differentiation (GO:0030854) | 3.68343380 |
| 54 | negative regulation of interleukin-8 production (GO:0032717) | 3.64794206 |
| 55 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.63732590 |
| 56 | negative regulation of growth of symbiont in host (GO:0044130) | 3.63590647 |
| 57 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.63590647 |
| 58 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.63590647 |
| 59 | regulation of growth of symbiont in host (GO:0044126) | 3.63590647 |
| 60 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.54496801 |
| 61 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.54496801 |
| 62 | lymphocyte apoptotic process (GO:0070227) | 3.53956404 |
| 63 | negative regulation of phagocytosis (GO:0050765) | 3.53437971 |
| 64 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.53426662 |
| 65 | mature B cell differentiation involved in immune response (GO:0002313) | 3.45775982 |
| 66 | positive regulation of macrophage differentiation (GO:0045651) | 3.43863577 |
| 67 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.42359992 |
| 68 | negative regulation of bone resorption (GO:0045779) | 3.41226254 |
| 69 | actin filament capping (GO:0051693) | 3.39457931 |
| 70 | cellular extravasation (GO:0045123) | 3.36178819 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33167882 |
| 72 | positive regulation of exocytosis (GO:0045921) | 3.25825269 |
| 73 | regulation of hematopoietic progenitor cell differentiation (GO:1901532) | 3.22886194 |
| 74 | heparin biosynthetic process (GO:0030210) | 3.22101804 |
| 75 | heparin metabolic process (GO:0030202) | 3.22101804 |
| 76 | leukocyte apoptotic process (GO:0071887) | 3.21531465 |
| 77 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.17152264 |
| 78 | regulation of B cell differentiation (GO:0045577) | 3.16562935 |
| 79 | hydrogen peroxide catabolic process (GO:0042744) | 3.14629520 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 3.11937588 |
| 81 | unsaturated fatty acid biosynthetic process (GO:0006636) | 3.11246310 |
| 82 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.10869017 |
| 83 | reactive oxygen species biosynthetic process (GO:1903409) | 3.10752182 |
| 84 | negative regulation of meiosis (GO:0045835) | 3.10646365 |
| 85 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.10596113 |
| 86 | regulation of macrophage differentiation (GO:0045649) | 3.10164795 |
| 87 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.07424725 |
| 88 | * peptide hormone processing (GO:0016486) | 3.05447143 |
| 89 | secretory granule organization (GO:0033363) | 3.01473768 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 3.00045169 |
| 91 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.98050886 |
| 92 | response to peptidoglycan (GO:0032494) | 2.95889223 |
| 93 | regulation of B cell mediated immunity (GO:0002712) | 2.95056310 |
| 94 | bone remodeling (GO:0046849) | 2.94352265 |
| 95 | mRNA transcription (GO:0009299) | 2.92642970 |
| 96 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.92635578 |
| 97 | antibacterial humoral response (GO:0019731) | 2.92564424 |
| 98 | regulation of activated T cell proliferation (GO:0046006) | 2.91692179 |
| 99 | homeostasis of number of cells within a tissue (GO:0048873) | 2.88937890 |
| 100 | antimicrobial humoral response (GO:0019730) | 2.88660241 |
| 101 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.87560893 |
| 102 | deoxyribonucleotide catabolic process (GO:0009264) | 2.86634807 |
| 103 | catecholamine biosynthetic process (GO:0042423) | 2.86198972 |
| 104 | catechol-containing compound biosynthetic process (GO:0009713) | 2.86198972 |
| 105 | peroxisome fission (GO:0016559) | 2.85878647 |
| 106 | hemoglobin metabolic process (GO:0020027) | 2.84569992 |
| 107 | leukocyte degranulation (GO:0043299) | 2.84190064 |
| 108 | pinocytosis (GO:0006907) | 2.83911151 |
| 109 | regulation of granulocyte differentiation (GO:0030852) | 2.83782287 |
| 110 | deoxyribose phosphate catabolic process (GO:0046386) | 2.83373601 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79579922 |
| 112 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.79033178 |
| 113 | negative regulation of B cell apoptotic process (GO:0002903) | 2.77976861 |
| 114 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.76469404 |
| 115 | indolalkylamine metabolic process (GO:0006586) | 2.76191615 |
| 116 | myeloid leukocyte mediated immunity (GO:0002444) | 2.74854117 |
| 117 | lysosome localization (GO:0032418) | 2.74542761 |
| 118 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.74108748 |
| 119 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.73501318 |
| 120 | Peyers patch development (GO:0048541) | 2.73501318 |
| 121 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.73468395 |
| 122 | cellular response to dsRNA (GO:0071359) | 2.72896069 |
| 123 | regulation of respiratory burst (GO:0060263) | 2.72845511 |
| 124 | endosome to melanosome transport (GO:0035646) | 2.72559045 |
| 125 | endosome to pigment granule transport (GO:0043485) | 2.72559045 |
| 126 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.72330450 |
| 127 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.72330450 |
| 128 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.71980789 |
| 129 | UV protection (GO:0009650) | 2.71241310 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.70062349 |
| 131 | centriole replication (GO:0007099) | 2.69534063 |
| 132 | neutrophil activation involved in immune response (GO:0002283) | 2.69449545 |
| 133 | negative regulation of bone remodeling (GO:0046851) | 2.68677914 |
| 134 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.68272874 |
| 135 | microglial cell activation (GO:0001774) | 2.68231494 |
| 136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67644074 |
| 137 | regulation of B cell apoptotic process (GO:0002902) | 2.66871762 |
| 138 | negative regulation of acute inflammatory response (GO:0002674) | 2.66374395 |
| 139 | negative regulation of bone mineralization (GO:0030502) | 2.65673431 |
| 140 | innate immune response in mucosa (GO:0002227) | 2.65475573 |
| 141 | mammary gland alveolus development (GO:0060749) | 2.65313657 |
| 142 | embryonic hemopoiesis (GO:0035162) | 2.64475710 |
| 143 | negative regulation of macrophage differentiation (GO:0045650) | 2.63828969 |
| 144 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.63201282 |
| 145 | negative regulation of actin filament depolymerization (GO:0030835) | 2.62721191 |
| 146 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.62625117 |
| 147 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.59972032 |
| 148 | activation of JUN kinase activity (GO:0007257) | 2.55783827 |
| 149 | positive regulation of myeloid cell differentiation (GO:0045639) | 2.54225453 |
| 150 | production of molecular mediator of immune response (GO:0002440) | 2.54216716 |
| 151 | granulocyte differentiation (GO:0030851) | 2.52248885 |
| 152 | amine biosynthetic process (GO:0009309) | 2.51970210 |
| 153 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.51970210 |
| 154 | histamine secretion (GO:0001821) | 2.42183101 |
| 155 | regulation of erythrocyte differentiation (GO:0045646) | 2.40694865 |
| 156 | negative regulation of actin filament polymerization (GO:0030837) | 2.38440292 |
| 157 | regulation of calcium-mediated signaling (GO:0050848) | 2.34804363 |
| 158 | lung lobe morphogenesis (GO:0060463) | 2.33498251 |
| 159 | negative regulation of granulocyte differentiation (GO:0030853) | 2.32041442 |
| 160 | cellular response to glucose stimulus (GO:0071333) | 2.31848337 |
| 161 | lymphoid progenitor cell differentiation (GO:0002320) | 2.30558931 |
| 162 | myeloid cell development (GO:0061515) | 2.28285245 |
| 163 | negative regulation of tissue remodeling (GO:0034104) | 2.22017406 |
| 164 | positive regulation of mast cell degranulation (GO:0043306) | 15.8531101 |
| 165 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 15.8531101 |
| 166 | regulation of hypersensitivity (GO:0002883) | 13.9433556 |
| 167 | positive regulation of mast cell activation (GO:0033005) | 13.1558066 |
| 168 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 12.8205306 |
| 169 | positive regulation of megakaryocyte differentiation (GO:0045654) | 12.5165871 |
| 170 | positive regulation of leukocyte degranulation (GO:0043302) | 11.7340335 |
| 171 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 10.8940317 |
| 172 | production of molecular mediator involved in inflammatory response (GO:0002532) | 10.1267954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 6.16468038 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.50552061 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57595739 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.55291488 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.32222577 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86737274 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.70462606 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66006814 |
| 9 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.65388676 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.59792128 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55005996 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.52569571 |
| 13 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.50604527 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41426323 |
| 15 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.38977805 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35983850 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.35858697 |
| 18 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.30175477 |
| 19 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.27408259 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.11909931 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02839555 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 12.3456622 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95699676 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94645147 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.91972264 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82877995 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81871536 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81373020 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76961004 |
| 30 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.76612215 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76541174 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73882014 |
| 33 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71969043 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70188766 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69295828 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69145876 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68446065 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.68177071 |
| 39 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.65989031 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63905265 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62726680 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60790053 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60636595 |
| 44 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.60428726 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59692119 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58064201 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57742987 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55937231 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53591096 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49315041 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46481367 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45802211 |
| 53 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.45594027 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.42768141 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37744876 |
| 56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33581911 |
| 57 | MYB_26560356_Chip-Seq_TH1_Human | 1.33448984 |
| 58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33069459 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28978568 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27588371 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25691112 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25388004 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24177608 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20300830 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20276546 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18533052 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14830521 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13505035 |
| 69 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12929277 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11898094 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11276722 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10638337 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10375483 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09451620 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08008690 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07013884 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05375037 |
| 78 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.04000219 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02935987 |
| 80 | P300_27268052_Chip-Seq_Bcells_Human | 1.02815106 |
| 81 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02083778 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01728601 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01525743 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01249821 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97977457 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97919032 |
| 87 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97872306 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96356192 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93725339 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93126327 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92752285 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91410597 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91296980 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91114192 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90030746 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89673014 |
| 97 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89218726 |
| 98 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88366211 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.86261015 |
| 100 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.85104621 |
| 101 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84866576 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 0.84561077 |
| 103 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84535885 |
| 104 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82780864 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82462701 |
| 106 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81958703 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81710345 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80692356 |
| 109 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.80032654 |
| 110 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79426982 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78334658 |
| 112 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.77990452 |
| 113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76991023 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76528087 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76467137 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76442260 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76141645 |
| 118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75333576 |
| 119 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.74686701 |
| 120 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71544938 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70804837 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70463867 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 0.70063671 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69811447 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68713211 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.68122103 |
| 127 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.67214627 |
| 128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.66979506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 5.91072777 |
| 2 | MP0000465_gastrointestinal_hemorrhage | 5.04981835 |
| 3 | MP0004808_abnormal_hematopoietic_stem | 3.94797303 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.66785024 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.33849704 |
| 6 | MP0003436_decreased_susceptibility_to | 3.06938534 |
| 7 | MP0004147_increased_porphyrin_level | 2.84074982 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.69594308 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.60236002 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.57186448 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.42513776 |
| 12 | MP0001873_stomach_inflammation | 2.42044974 |
| 13 | MP0004782_abnormal_surfactant_physiolog | 2.40331651 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.37825198 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.37099560 |
| 16 | MP0002419_abnormal_innate_immunity | 2.36848457 |
| 17 | MP0001790_abnormal_immune_system | 2.35811937 |
| 18 | MP0005387_immune_system_phenotype | 2.35811937 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.34695193 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.30088962 |
| 21 | MP0005671_abnormal_response_to | 2.30012939 |
| 22 | MP0001819_abnormal_immune_cell | 2.28637272 |
| 23 | * MP0002398_abnormal_bone_marrow | 2.21258545 |
| 24 | MP0008775_abnormal_heart_ventricle | 2.19427476 |
| 25 | MP0001800_abnormal_humoral_immune | 2.13593789 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.10511351 |
| 27 | MP0005025_abnormal_response_to | 2.08300857 |
| 28 | MP0002735_abnormal_chemical_nociception | 2.06610251 |
| 29 | MP0003303_peritoneal_inflammation | 2.01943773 |
| 30 | MP0002723_abnormal_immune_serum | 1.92188273 |
| 31 | MP0001188_hyperpigmentation | 1.91652744 |
| 32 | MP0000343_altered_response_to | 1.87415253 |
| 33 | MP0004858_abnormal_nervous_system | 1.85028275 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.83126217 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.81928932 |
| 36 | MP0010307_abnormal_tumor_latency | 1.81446551 |
| 37 | MP0003866_abnormal_defecation | 1.77052087 |
| 38 | MP0006082_CNS_inflammation | 1.73243130 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.72898294 |
| 40 | MP0002971_abnormal_brown_adipose | 1.71872614 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.65978661 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.65978661 |
| 43 | MP0002405_respiratory_system_inflammati | 1.65636892 |
| 44 | MP0000249_abnormal_blood_vessel | 1.63329249 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.62321816 |
| 46 | * MP0002722_abnormal_immune_system | 1.61795522 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.59949401 |
| 48 | MP0008770_decreased_survivor_rate | 1.59845281 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.59669286 |
| 50 | MP0008995_early_reproductive_senescence | 1.59580381 |
| 51 | MP0004883_abnormal_blood_vessel | 1.59273202 |
| 52 | MP0009115_abnormal_fat_cell | 1.56900698 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.55156983 |
| 54 | * MP0000716_abnormal_immune_system | 1.54313906 |
| 55 | MP0000516_abnormal_urinary_system | 1.48756414 |
| 56 | MP0005367_renal/urinary_system_phenotyp | 1.48756414 |
| 57 | MP0001853_heart_inflammation | 1.47470884 |
| 58 | * MP0002429_abnormal_blood_cell | 1.47151380 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.44978026 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.44280609 |
| 61 | MP0002009_preneoplasia | 1.43007254 |
| 62 | MP0004885_abnormal_endolymph | 1.37037384 |
| 63 | MP0008961_abnormal_basal_metabolism | 1.32202775 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.30724795 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.29609154 |
| 66 | MP0008469_abnormal_protein_level | 1.29496803 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.28754275 |
| 68 | MP0004510_myositis | 1.28634928 |
| 69 | MP0000681_abnormal_thyroid_gland | 1.21614670 |
| 70 | MP0005360_urolithiasis | 1.20185910 |
| 71 | MP0003329_amyloid_beta_deposits | 1.15567092 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.15465557 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.14934112 |
| 74 | MP0000372_irregular_coat_pigmentation | 1.07734175 |
| 75 | MP0009785_altered_susceptibility_to | 1.07351601 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.07057989 |
| 77 | MP0004947_skin_inflammation | 1.05667307 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 1.05596422 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05421190 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.05347416 |
| 81 | MP0009278_abnormal_bone_marrow | 1.04406544 |
| 82 | MP0005310_abnormal_salivary_gland | 1.03883969 |
| 83 | MP0001851_eye_inflammation | 1.03611694 |
| 84 | MP0000685_abnormal_immune_system | 1.01964395 |
| 85 | MP0002796_impaired_skin_barrier | 0.95299424 |
| 86 | MP0000490_abnormal_crypts_of | 0.92602153 |
| 87 | MP0002938_white_spotting | 0.91986227 |
| 88 | MP0005448_abnormal_energy_balance | 0.91222979 |
| 89 | MP0009764_decreased_sensitivity_to | 0.88941755 |
| 90 | MP0003828_pulmonary_edema | 0.88084760 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.88047156 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.87840541 |
| 93 | MP0005164_abnormal_response_to | 0.87303471 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.87165447 |
| 95 | MP0002006_tumorigenesis | 0.84950773 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.84573897 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.84502068 |
| 98 | MP0005503_abnormal_tendon_morphology | 0.83573280 |
| 99 | MP0002970_abnormal_white_adipose | 0.83518179 |
| 100 | MP0005390_skeleton_phenotype | 0.82806809 |
| 101 | MP0005166_decreased_susceptibility_to | 0.81627681 |
| 102 | MP0001881_abnormal_mammary_gland | 0.80282495 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.79306197 |
| 104 | MP0001764_abnormal_homeostasis | 0.78648985 |
| 105 | MP0003795_abnormal_bone_structure | 0.78369607 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.77982013 |
| 107 | MP0001970_abnormal_pain_threshold | 0.77036586 |
| 108 | MP0000604_amyloidosis | 0.76972133 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.76852715 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.76716829 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.76175150 |
| 112 | MP0009840_abnormal_foam_cell | 0.75839385 |
| 113 | MP0001666_abnormal_nutrient_absorption | 0.75149819 |
| 114 | * MP0000703_abnormal_thymus_morphology | 0.74510828 |
| 115 | MP0002095_abnormal_skin_pigmentation | 0.73543703 |
| 116 | MP0005535_abnormal_body_temperature | 0.71606673 |
| 117 | MP0001542_abnormal_bone_strength | 0.70194898 |
| 118 | MP0002254_reproductive_system_inflammat | 0.69537603 |
| 119 | MP0008057_abnormal_DNA_replication | 0.69136778 |
| 120 | MP0000858_altered_metastatic_potential | 0.69118130 |
| 121 | MP0008874_decreased_physiological_sensi | 0.69115201 |
| 122 | MP0003724_increased_susceptibility_to | 0.66578672 |
| 123 | MP0001663_abnormal_digestive_system | 0.65333205 |
| 124 | * MP0003638_abnormal_response/metabolism_ | 0.65080770 |
| 125 | * MP0009765_abnormal_xenobiotic_induced | 0.64864615 |
| 126 | MP0006054_spinal_hemorrhage | 0.64267654 |
| 127 | * MP0009763_increased_sensitivity_to | 0.62004593 |
| 128 | * MP0008873_increased_physiological_sensi | 0.61542352 |
| 129 | MP0002128_abnormal_blood_circulation | 0.59441025 |
| 130 | MP0001727_abnormal_embryo_implantation | 0.57100619 |
| 131 | MP0005334_abnormal_fat_pad | 0.54543930 |
| 132 | MP0005076_abnormal_cell_differentiation | 0.52977097 |
| 133 | MP0001915_intracranial_hemorrhage | 0.51976302 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.51813613 |
| 135 | MP0002733_abnormal_thermal_nociception | 0.51442809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.79559864 |
| 2 | Abnormal platelet volume (HP:0011876) | 9.55038473 |
| 3 | Purpura (HP:0000979) | 9.08845644 |
| 4 | Prolonged bleeding time (HP:0003010) | 8.96548231 |
| 5 | Menorrhagia (HP:0000132) | 8.79495842 |
| 6 | Abnormal platelet function (HP:0011869) | 8.37620412 |
| 7 | Impaired platelet aggregation (HP:0003540) | 8.37620412 |
| 8 | Gingival bleeding (HP:0000225) | 7.64946323 |
| 9 | Aplastic anemia (HP:0001915) | 5.19365709 |
| 10 | Acute lymphatic leukemia (HP:0006721) | 4.82696462 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.82373355 |
| 12 | Agammaglobulinemia (HP:0004432) | 4.79650358 |
| 13 | Epistaxis (HP:0000421) | 4.72956910 |
| 14 | Papilledema (HP:0001085) | 4.34482379 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 4.15306201 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.93976607 |
| 17 | Granulocytopenia (HP:0001913) | 3.73266725 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 3.57005336 |
| 19 | Esophageal neoplasm (HP:0100751) | 3.52390711 |
| 20 | Neoplasm of head and neck (HP:0012288) | 3.52390711 |
| 21 | White forelock (HP:0002211) | 3.51135513 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 3.36748948 |
| 23 | Cellulitis (HP:0100658) | 3.30768880 |
| 24 | Chronic otitis media (HP:0000389) | 3.29351181 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.28896104 |
| 26 | Obstructive lung disease (HP:0006536) | 3.28896104 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.27102959 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.27102959 |
| 29 | Heterochromia iridis (HP:0001100) | 3.16436373 |
| 30 | Patchy hypopigmentation of hair (HP:0011365) | 3.12870569 |
| 31 | Bruising susceptibility (HP:0000978) | 3.11615221 |
| 32 | Recurrent viral infections (HP:0004429) | 3.05449161 |
| 33 | Increased IgE level (HP:0003212) | 3.05193869 |
| 34 | Meningitis (HP:0001287) | 3.01505742 |
| 35 | Male infertility (HP:0003251) | 2.98579967 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.96680986 |
| 37 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.95841933 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.94073331 |
| 39 | Alveolar cell carcinoma (HP:0006519) | 2.91749519 |
| 40 | Hypergammaglobulinemia (HP:0010702) | 2.89920747 |
| 41 | Myositis (HP:0100614) | 2.87163527 |
| 42 | Failure to thrive in infancy (HP:0001531) | 2.86614626 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.82012956 |
| 44 | Poikilocytosis (HP:0004447) | 2.81528222 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.80770518 |
| 46 | Eosinophilia (HP:0001880) | 2.79122973 |
| 47 | Acute myeloid leukemia (HP:0004808) | 2.78388798 |
| 48 | Diplopia (HP:0000651) | 2.74922524 |
| 49 | Abnormality of binocular vision (HP:0011514) | 2.74922524 |
| 50 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.69918783 |
| 51 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.69339095 |
| 52 | Osteomyelitis (HP:0002754) | 2.64987099 |
| 53 | Periodontitis (HP:0000704) | 2.63593182 |
| 54 | Abnormality of oral frenula (HP:0000190) | 2.60614941 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.56035089 |
| 56 | B lymphocytopenia (HP:0010976) | 2.55454674 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.51866259 |
| 58 | IgM deficiency (HP:0002850) | 2.50840001 |
| 59 | Abnormality of T cells (HP:0002843) | 2.47437861 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.45316151 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.44567374 |
| 62 | Vasculitis (HP:0002633) | 2.41634279 |
| 63 | Skin rash (HP:0000988) | 2.37730588 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.37481003 |
| 65 | Neutropenia (HP:0001875) | 2.30175707 |
| 66 | Skin ulcer (HP:0200042) | 2.26926713 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.26497504 |
| 68 | Neurodegeneration (HP:0002180) | 2.24608344 |
| 69 | Chronic diarrhea (HP:0002028) | 2.23841598 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20218619 |
| 71 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.20212357 |
| 72 | Prostate neoplasm (HP:0100787) | 2.17362576 |
| 73 | Abnormal sex determination (HP:0012244) | 2.14473834 |
| 74 | Sex reversal (HP:0012245) | 2.14473834 |
| 75 | Slender build (HP:0001533) | 2.14067698 |
| 76 | Increased density of long bones (HP:0006392) | 2.13393761 |
| 77 | Sepsis (HP:0100806) | 2.11771917 |
| 78 | Hyperacusis (HP:0010780) | 2.09692990 |
| 79 | Cutaneous melanoma (HP:0012056) | 2.09075935 |
| 80 | Urticaria (HP:0001025) | 2.08102006 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06783907 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.06783907 |
| 83 | Cerebral palsy (HP:0100021) | 2.04379037 |
| 84 | Pustule (HP:0200039) | 2.03157224 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01891728 |
| 86 | Episodic fever (HP:0001954) | 2.01523658 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 2.00781226 |
| 88 | Petechiae (HP:0000967) | 12.7543956 |
| 89 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.99719270 |
| 90 | Villous atrophy (HP:0011473) | 1.99719270 |
| 91 | Germ cell neoplasia (HP:0100728) | 1.99618491 |
| 92 | Gingivitis (HP:0000230) | 1.98605290 |
| 93 | Abnormality of male internal genitalia (HP:0000022) | 1.97743415 |
| 94 | Thrombocytosis (HP:0001894) | 1.95819886 |
| 95 | Abnormality of eosinophils (HP:0001879) | 1.95710299 |
| 96 | Seborrheic dermatitis (HP:0001051) | 1.95024789 |
| 97 | Pulmonary fibrosis (HP:0002206) | 1.93524600 |
| 98 | Complement deficiency (HP:0004431) | 1.93385740 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92399069 |
| 100 | Abnormality of complement system (HP:0005339) | 1.91984008 |
| 101 | Type I transferrin isoform profile (HP:0003642) | 1.91323497 |
| 102 | Growth hormone excess (HP:0000845) | 1.90658067 |
| 103 | Insomnia (HP:0100785) | 1.89952694 |
| 104 | Stomatitis (HP:0010280) | 1.89465226 |
| 105 | Albinism (HP:0001022) | 1.88089259 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85788463 |
| 107 | Myelodysplasia (HP:0002863) | 1.85125236 |
| 108 | Hemoptysis (HP:0002105) | 1.85013280 |
| 109 | Abnormality of the pleura (HP:0002103) | 1.84287042 |
| 110 | Gonadal dysgenesis (HP:0000133) | 1.83869919 |
| 111 | Acute hepatic failure (HP:0006554) | 1.83778413 |
| 112 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81851666 |
| 113 | Mucopolysacchariduria (HP:0008155) | 1.81851666 |
| 114 | Pulmonary infiltrates (HP:0002113) | 1.81712593 |
| 115 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80836206 |
| 116 | Large hands (HP:0001176) | 1.80549674 |
| 117 | Leukocytosis (HP:0001974) | 1.79396737 |
| 118 | Hepatosplenomegaly (HP:0001433) | 1.78397244 |
| 119 | Recurrent skin infections (HP:0001581) | 1.77076866 |
| 120 | Nasal polyposis (HP:0100582) | 1.75146933 |
| 121 | Cervical subluxation (HP:0003308) | 1.73518325 |
| 122 | Hematochezia (HP:0002573) | 1.72031410 |
| 123 | Abnormality of the prostate (HP:0008775) | 1.71843232 |
| 124 | Cerebral aneurysm (HP:0004944) | 1.71167248 |
| 125 | Inflammation of the large intestine (HP:0002037) | 1.71108083 |
| 126 | Spontaneous hematomas (HP:0007420) | 1.70619726 |
| 127 | Gastrointestinal inflammation (HP:0004386) | 1.68543492 |
| 128 | Neoplasm of the rectum (HP:0100743) | 1.67168225 |
| 129 | Increased cerebral lipofuscin (HP:0011813) | 1.66498354 |
| 130 | Fibroma (HP:0010614) | 1.61247491 |
| 131 | Fibrous tissue neoplasm (HP:0012316) | 1.57677101 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.56341733 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.56341733 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.56341733 |
| 135 | Acrocyanosis (HP:0001063) | 1.54569236 |
| 136 | Severe short stature (HP:0003510) | 1.53705119 |
| 137 | Abnormality of the lumbar spine (HP:0100712) | 1.52417932 |
| 138 | Disproportionate tall stature (HP:0001519) | 1.50832266 |
| 139 | Depressed nasal tip (HP:0000437) | 1.50060917 |
| 140 | Neoplasm of the small intestine (HP:0100833) | 1.48201344 |
| 141 | Apathy (HP:0000741) | 1.47390696 |
| 142 | Erythema (HP:0010783) | 1.46735374 |
| 143 | Easy fatigability (HP:0003388) | 1.44754227 |
| 144 | Chest pain (HP:0100749) | 1.43303919 |
| 145 | Abnormality of the nasal mucosa (HP:0000433) | 1.42531221 |
| 146 | Supranuclear gaze palsy (HP:0000605) | 1.42459767 |
| 147 | Abnormality of lateral ventricle (HP:0030047) | 1.42286133 |
| 148 | Synophrys (HP:0000664) | 1.41658618 |
| 149 | Amyotrophic lateral sclerosis (HP:0007354) | 1.40540433 |
| 150 | Diminished motivation (HP:0000745) | 1.38333639 |
| 151 | Panhypogammaglobulinemia (HP:0003139) | 1.38324228 |
| 152 | Encephalitis (HP:0002383) | 1.37140095 |
| 153 | Broad palm (HP:0001169) | 1.36435325 |
| 154 | Lymphedema (HP:0001004) | 1.35507188 |
| 155 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.35228996 |
| 156 | Arterial thrombosis (HP:0004420) | 1.34325036 |
| 157 | Pallor (HP:0000980) | 1.32028464 |
| 158 | Colitis (HP:0002583) | 1.31340522 |
| 159 | Sudden cardiac death (HP:0001645) | 1.26855692 |
| 160 | Mediastinal lymphadenopathy (HP:0100721) | 1.26739242 |
| 161 | Trigonocephaly (HP:0000243) | 1.26526809 |
| 162 | Vacuolated lymphocytes (HP:0001922) | 1.24922274 |
| 163 | Beaking of vertebral bodies (HP:0004568) | 1.23519523 |
| 164 | Ankyloglossia (HP:0010296) | 1.23343999 |
| 165 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.22794158 |
| 166 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.22104804 |
| 167 | Viral hepatitis (HP:0006562) | 1.20917058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 6.68508950 |
| 2 | EEF2K | 5.53069030 |
| 3 | MATK | 4.48431386 |
| 4 | TRIM28 | 4.01006390 |
| 5 | MAP4K1 | 3.45889248 |
| 6 | BCKDK | 3.19923800 |
| 7 | ERN1 | 3.14579311 |
| 8 | TXK | 2.82547042 |
| 9 | FLT3 | 2.66846710 |
| 10 | RIPK4 | 2.59669959 |
| 11 | MAPKAPK3 | 2.55902687 |
| 12 | FES | 2.48384755 |
| 13 | PIM2 | 2.37658485 |
| 14 | BMPR2 | 2.33751798 |
| 15 | PRPF4B | 2.24959833 |
| 16 | MAPKAPK5 | 2.23276142 |
| 17 | CDK6 | 2.21626487 |
| 18 | TAOK3 | 1.99505154 |
| 19 | NTRK2 | 1.92178199 |
| 20 | CSF1R | 1.86146847 |
| 21 | TRIB3 | 1.80282781 |
| 22 | TRPM7 | 1.73684029 |
| 23 | RPS6KB2 | 1.70294807 |
| 24 | ITK | 1.65262350 |
| 25 | SCYL2 | 1.63898827 |
| 26 | ZAP70 | 1.53349887 |
| 27 | SYK | 1.52629124 |
| 28 | IKBKE | 1.43176296 |
| 29 | FGFR2 | 1.33905445 |
| 30 | NME1 | 1.32091549 |
| 31 | MAPKAPK2 | 1.31216006 |
| 32 | GRK6 | 1.30915950 |
| 33 | BTK | 1.29439847 |
| 34 | NME2 | 1.27667185 |
| 35 | JAK2 | 1.23311128 |
| 36 | TGFBR2 | 1.18516030 |
| 37 | TYK2 | 1.18428265 |
| 38 | LYN | 1.18032740 |
| 39 | PKN2 | 1.16768550 |
| 40 | MAP3K14 | 1.16706882 |
| 41 | PDK2 | 1.16487232 |
| 42 | ABL2 | 1.13791079 |
| 43 | TEC | 1.11891593 |
| 44 | MAP2K2 | 1.10777220 |
| 45 | FER | 1.10031427 |
| 46 | NEK9 | 1.08642139 |
| 47 | LRRK2 | 1.06476519 |
| 48 | IRAK4 | 1.06198937 |
| 49 | IKBKB | 1.05740291 |
| 50 | STK10 | 1.05258995 |
| 51 | MAP3K12 | 1.03493560 |
| 52 | PIM1 | 1.02770446 |
| 53 | ACVR1B | 1.00752341 |
| 54 | SIK2 | 0.99596215 |
| 55 | CDC7 | 0.97452445 |
| 56 | CSNK1G3 | 0.94899929 |
| 57 | TAOK1 | 0.92351662 |
| 58 | FGFR3 | 0.90749788 |
| 59 | FGFR4 | 0.89770137 |
| 60 | MAP3K1 | 0.86326832 |
| 61 | PTK6 | 0.86228954 |
| 62 | MARK3 | 0.83367346 |
| 63 | NUAK1 | 0.82109993 |
| 64 | TNIK | 0.81753908 |
| 65 | CDK4 | 0.81174989 |
| 66 | ALK | 0.80266938 |
| 67 | PRKACG | 0.78090314 |
| 68 | MUSK | 0.76617041 |
| 69 | NEK2 | 0.74920575 |
| 70 | PRKACB | 0.73759880 |
| 71 | TIE1 | 0.72680376 |
| 72 | PIK3CA | 0.72462566 |
| 73 | BMX | 0.72394940 |
| 74 | RPS6KA2 | 0.72348343 |
| 75 | BLK | 0.72203272 |
| 76 | TAOK2 | 0.72015853 |
| 77 | GRK7 | 0.71991169 |
| 78 | IRAK3 | 0.71405859 |
| 79 | MAP2K6 | 0.71209474 |
| 80 | EIF2AK3 | 0.70731819 |
| 81 | HIPK2 | 0.66836739 |
| 82 | MKNK1 | 0.66032790 |
| 83 | MAP3K6 | 0.65179054 |
| 84 | ERBB3 | 0.64051153 |
| 85 | VRK2 | 0.63232368 |
| 86 | GSK3A | 0.63221589 |
| 87 | MAPK11 | 0.62603211 |
| 88 | LCK | 0.62304756 |
| 89 | MAP3K7 | 0.61787508 |
| 90 | HCK | 0.61138312 |
| 91 | CSNK1G2 | 0.60762802 |
| 92 | TGFBR1 | 0.57468310 |
| 93 | RPS6KC1 | 0.56197373 |
| 94 | RPS6KL1 | 0.56197373 |
| 95 | RPS6KA4 | 0.52603524 |
| 96 | RPS6KA6 | 0.51224390 |
| 97 | CSK | 0.51190765 |
| 98 | PRKD2 | 0.50963658 |
| 99 | VRK1 | 0.50485407 |
| 100 | CSNK1G1 | 0.50475336 |
| 101 | MAP3K13 | 0.50045579 |
| 102 | CAMK1G | 0.49027384 |
| 103 | PAK2 | 0.48766298 |
| 104 | TESK2 | 0.48655811 |
| 105 | JAK3 | 0.48500708 |
| 106 | ABL1 | 0.48138756 |
| 107 | KDR | 0.47592466 |
| 108 | PRKCQ | 0.47135530 |
| 109 | MAP4K2 | 0.46890879 |
| 110 | DAPK2 | 0.45934618 |
| 111 | MAP3K11 | 0.44842833 |
| 112 | CAMK1D | 0.43262895 |
| 113 | CAMKK2 | 0.42698960 |
| 114 | CDK12 | 0.42469039 |
| 115 | PDK1 | 0.41996007 |
| 116 | MAPK15 | 0.40206471 |
| 117 | EPHB1 | 0.38980540 |
| 118 | IRAK1 | 0.37194777 |
| 119 | PRKCD | 0.36083203 |
| 120 | PDPK1 | 0.35535406 |
| 121 | PIK3CG | 0.34836282 |
| 122 | DYRK1B | 0.34562353 |
| 123 | ILK | 0.34504927 |
| 124 | RPS6KA5 | 0.33685934 |
| 125 | PRKCB | 0.33679585 |
| 126 | MARK2 | 0.33612643 |
| 127 | ATR | 0.33358542 |
| 128 | MAP3K2 | 0.33119659 |
| 129 | CAMKK1 | 0.32460168 |
| 130 | WEE1 | 0.32423629 |
| 131 | DAPK1 | 0.31914181 |
| 132 | STK4 | 0.31749168 |
| 133 | CDK19 | 0.31492738 |
| 134 | SIK1 | 0.31464979 |
| 135 | MOS | 0.31212647 |
| 136 | TNK2 | 0.30954608 |
| 137 | PAK4 | 0.30589589 |
| 138 | TBK1 | 0.30172050 |
| 139 | MAPK4 | 0.29825703 |
| 140 | SRC | 0.29443213 |
| 141 | MAP3K8 | 0.29084594 |
| 142 | UHMK1 | 0.28467974 |
| 143 | PDGFRA | 0.27922389 |
| 144 | MAPK13 | 0.27220851 |
| 145 | TYRO3 | 0.26385361 |
| 146 | TLK1 | 0.25223513 |
| 147 | JAK1 | 0.23148356 |
| 148 | MAPK3 | 0.21924574 |
| 149 | MAP2K3 | 0.21813912 |
| 150 | CLK1 | 0.21356198 |
| 151 | FYN | 0.20977981 |
| 152 | DAPK3 | 0.20731812 |
| 153 | MAP2K1 | 0.20481815 |
| 154 | CDK7 | 0.20453456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 6.19696234 |
| 2 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 3.82381676 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 3.47304172 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.38501387 |
| 5 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.13744400 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.12304669 |
| 7 | Platelet activation_Homo sapiens_hsa04611 | 2.04747245 |
| 8 | Asthma_Homo sapiens_hsa05310 | 10.9141370 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98468835 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82806870 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82309411 |
| 12 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.81508600 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74566923 |
| 14 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.71695986 |
| 15 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.61115142 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56702203 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44752113 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44203127 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39484069 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.38989117 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34067725 |
| 22 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.33920812 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31050357 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.30134066 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28296385 |
| 26 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.25709002 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.24191238 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.22743422 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18615456 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18114740 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17992195 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17865319 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.17006076 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15650410 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13992174 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13759991 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13046703 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.11990626 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10564028 |
| 40 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09001544 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08764375 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07520919 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06666053 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05492500 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03210129 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02022851 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01369936 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99824608 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98332387 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98033876 |
| 51 | DNA replication_Homo sapiens_hsa03030 | 0.97697873 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94227991 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 0.91867674 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.91554243 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91307265 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90744890 |
| 57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90654513 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.88683621 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88011229 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87177779 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85721196 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.85130732 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84014543 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.83026108 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81913497 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.81891215 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81572002 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81368641 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78036306 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.77021680 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73706369 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.71689606 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71367663 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70789623 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70788453 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70721481 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68881530 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66392782 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66273593 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66085814 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65297940 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61349171 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.61152460 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56861649 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55715333 |
| 86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55441345 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55260694 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53507869 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.53060113 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52255768 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51031607 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.49668567 |
| 93 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.48890650 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48427617 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47986388 |
| 96 | Homologous recombination_Homo sapiens_hsa03440 | 0.46667233 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44046714 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44039333 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42857457 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42497682 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41673073 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41012768 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40830765 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40184329 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39145364 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39102160 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38844939 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38236399 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.37102339 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36425822 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36167351 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35004333 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.34941012 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34042980 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.33970672 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.33955945 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.32887751 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.32861705 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32317448 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31992724 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31960900 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.31032776 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30833503 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29823629 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29594711 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29070644 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.28317680 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.28044046 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27109638 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26987723 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26441881 |
| 132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.26111969 |
| 133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25821389 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25409131 |
| 135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.25292161 |
| 136 | Mismatch repair_Homo sapiens_hsa03430 | 0.24791271 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23037085 |
| 138 | Allograft rejection_Homo sapiens_hsa05330 | 0.22331347 |
| 139 | Gap junction_Homo sapiens_hsa04540 | 0.21998277 |
| 140 | Tuberculosis_Homo sapiens_hsa05152 | 0.21961993 |
| 141 | Cell cycle_Homo sapiens_hsa04110 | 0.21363918 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20028959 |
| 143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19705923 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18665274 |
| 145 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18372325 |
| 146 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.17986686 |
| 147 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.17725302 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.17435828 |
| 149 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16905607 |
| 150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16071643 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15528317 |
| 152 | Insulin resistance_Homo sapiens_hsa04931 | 0.14902762 |
| 153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.14270993 |
| 154 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14250944 |
| 155 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14143103 |
| 156 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.13978583 |
| 157 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13952160 |
| 158 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13761080 |
| 159 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11919522 |
| 160 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.11820067 |

